Prime Minister Gaston Browne of Antigua and Barbuda has taken a bold step in advocating for universal eye health, addressing a United Nations side-event titled “The Value of Vision: The Case for Investment.” The event, held on Wednesday, emphasized the urgent need for global investment to combat avoidable vision loss and its far-reaching social and economic impacts. Reflecting on the 2021 UN Resolution “Vision for Everyone,” co-sponsored by Bangladesh, Ireland, and Antigua and Barbuda, Browne highlighted the slow progress in addressing vision impairment, which continues to hinder millions from leading dignified lives. He stressed that investing in eye health is not merely an act of charity but a strategic economic move that enhances productivity, prosperity, and resilience, particularly for small nations like Antigua and Barbuda. Citing a recent study by the International Agency for the Prevention of Blindness (IAPB), Seva Foundation, and the Fred Hollows Foundation, Browne outlined the potential global benefits of scaling vision care, including $447 billion in annual economic returns, 22 million new jobs, and 13 million additional school years for children. To translate this momentum into tangible outcomes, Browne announced that Antigua and Barbuda will host the inaugural Global Summit on Eye Health in 2026. This summit aims to bring together leaders, private sector stakeholders, and civil society to commit to actionable, time-bound initiatives that restore sight, potential, and hope. Browne called on governments, investors, and development partners to align their policies and portfolios with universal eye-health goals, emphasizing the need for innovation, data-driven strategies, and large-scale delivery. He concluded with a stark choice: either allow vision loss to continue robbing the world of talent and productivity or act decisively to reap the immense benefits that are within reach. The time for action, he asserted, is now.
分类: health
-

Bellevue Hospital CEO cops top honour at Australian Mental Health Foundation awards
KINGSTON, Jamaica — Suzette Buchanan, CEO of Bellevue Hospital, has been awarded the prestigious title of International Mental Health Advocate of the Year by the Mental Health Foundation Australia (MHFA). Buchanan will travel to Melbourne on October 4 to receive the accolade at the 8th Annual Australian Mental Health Awards, coinciding with Australia’s National Multicultural Mental Health Month. She is among six honorees recognized this year for their exceptional contributions to mental health awareness and stigma reduction. Buchanan’s leadership at Bellevue Hospital and her role as host of the groundbreaking mental health television series *MindSet* were key factors in her selection. With over 14 years of experience in health, media, and public service governance, Buchanan has championed national reforms and combatted mental health stigma through both policy and storytelling. A Harvard-trained Mental Health Leadership graduate, she combines strategic vision with personal experience and empathy, ensuring her work prioritizes individuals and communities. “This award is deeply personal. My work at Bellevue, the creation of *MindSet*, and supporting my daughter living with bipolar disorder have driven my mission to break the silence and dismantle stigma,” Buchanan shared. She dedicated the honor to individuals and families facing mental health challenges, including the over 400 unsupported social cases at Bellevue Hospital, reaffirming her commitment to advocacy, awareness, and healing. Buchanan’s recognition highlights Jamaica’s expanding influence in global mental health advocacy, positioning the nation as a key contributor to international discussions on care, resilience, and stigma reduction. The Mental Health Foundation Australia, the country’s oldest mental health association, celebrates innovative and impactful leadership in mental health through its awards, emphasizing the value of cross-cultural collaboration and diverse perspectives in shaping global mental health strategies.
-

OP-ED: Why back-to-school time shouldn’t mean back to unhealthy food marketing
As a parent navigating the ‘First Day of School’ milestone, the experience was both exhilarating and daunting. Months of preparation went into gathering essentials for my toddler’s preschool journey. However, this transition also unveiled a troubling reality: the pervasive and unethical marketing of unhealthy, ultra-processed foods targeted at children. These products, often disguised as lunchbox necessities, are cleverly designed to appeal to young minds, undermining efforts to promote healthy eating habits.
-

Paracetamol does not cause autism, says expert
Santo Domingo – The World Health Organization (WHO) has officially stated that there is no scientific evidence connecting the use of paracetamol during pregnancy to autism in children. This declaration comes in response to recent assertions made by former U.S. President Donald Trump, who advocated for limiting the use of Tylenol (a brand of paracetamol) among pregnant women and newborns. The WHO’s stance aims to dispel misinformation and reassure the public about the safety of this widely used medication. Dr. Rafael Montero, a public health specialist, strongly criticized Trump’s comments during an interview on Esto No Tiene Nombre, labeling them as baseless and unsupported by scientific research. Montero explained that paracetamol, whose active ingredient is acetaminophen, has been safely utilized for decades with no evidence linking it to autism spectrum disorder. He attributed the increase in autism diagnoses to enhanced detection methods and greater public awareness rather than medication use. Montero also pointed out that Trump had misinterpreted a Johns Hopkins meta-analysis, presenting it as conclusive evidence when it was not. Additionally, he questioned Trump’s focus on the Tylenol brand instead of the active compound, deeming it inappropriate. Montero emphasized the importance of patients consulting their healthcare providers for medical advice, a position echoed by the Dominican Society of Gynecologists, which reaffirmed the safety of acetaminophen when prescribed.
-

‘I had no symptoms’—Christopher Denny urges Jamaican men to take prostate cancer seriously
KINGSTON, Jamaica — Christopher Denny’s life took an unexpected turn during his routine annual check-up in February 2022. What he anticipated as a standard health assessment revealed a concerning anomaly: his Prostate-Specific Antigen (PSA) levels were slightly elevated at 4.65. This marked the beginning of a transformative two-year journey filled with medical tests, uncertainty, and life-altering decisions.





